Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction
Authors
Keywords
Cardioprotection, β3 adrenergic receptor, Ischemia/reperfusion injury, Acute myocardial infarction, Translational models, Mirabegron
Journal
Journal of Cardiovascular Translational Research
Volume 11, Issue 4, Pages 310-318
Publisher
Springer Nature America, Inc
Online
2018-08-03
DOI
10.1007/s12265-018-9819-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reflection of Cardioprotection by Remote Ischemic Perconditioning in Attenuated ST-Segment Elevation During Ongoing Coronary Occlusion in PigsNovelty and Significance
- (2018) Petra Kleinbongard et al. CIRCULATION RESEARCH
- Infarct Size Reduction by Targeting Ischemic Injury
- (2018) Xavier Rossello et al. CIRCULATION RESEARCH
- Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortality
- (2017) Xavier Rosselló et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Translational science approach for assessment of cardiovascular effects and proarrhythmogenic potential of the beta-3 adrenergic agonist mirabegron
- (2017) Cees Korstanje et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension
- (2016) Ana García-Álvarez et al. BASIC RESEARCH IN CARDIOLOGY
- Cardiac salvage by tweaking with beta-3-adrenergic receptors
- (2016) Jean-Luc Balligand CARDIOVASCULAR RESEARCH
- Cardioprotection
- (2016) Xavier Rossello et al. CIRCULATION
- Cardiovascular disease in Europe: epidemiological update 2016
- (2016) Nick Townsend et al. EUROPEAN HEART JOURNAL
- The first-in-man randomized trial of a beta3 adrenoceptor agonist in chronic heart failure: the BEAT-HF trial
- (2016) Henning Bundgaard et al. EUROPEAN JOURNAL OF HEART FAILURE
- Remote ischaemic conditioning and healthcare system delay in patients with ST-segment elevation myocardial infarction
- (2016) Kasper Pryds et al. HEART
- Relationship Between Infarct Size and Outcomes Following Primary PCI
- (2016) Gregg W. Stone et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Impact of the Timing of Metoprolol Administration During STEMI on Infarct Size and Ventricular Function
- (2016) Jose M. García-Ruiz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Characterization of the Langendorff Perfused Isolated Mouse Heart Model of Global Ischemia–Reperfusion Injury
- (2015) Xavier Rossello et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Myocardial Edema After Ischemia/Reperfusion Is Not Stable and Follows a Bimodal Pattern
- (2015) Rodrigo Fernández-Jiménez et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pathophysiology Underlying the Bimodal Edema Phenomenon After Myocardial Ischemia/Reperfusion
- (2015) Rodrigo Fernández-Jiménez et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Evolving Therapies for Myocardial Ischemia/Reperfusion Injury
- (2015) Borja Ibáñez et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Contrast-Enhanced CMR Overestimates Early Myocardial Infarct Size
- (2015) Robert Jablonowski et al. JACC-Cardiovascular Imaging
- β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes
- (2014) Jaime García-Prieto et al. BASIC RESEARCH IN CARDIOLOGY
- Top 10 cardiovascular therapies and interventions for the next decade
- (2014) Valentin Fuster Nature Reviews Cardiology
- β3-Adrenoreceptor Stimulation Protects against Myocardial Infarction Injury via eNOS and nNOS Activation
- (2014) Xiaolin Niu et al. PLoS One
- Enhanced Expression of β3-Adrenoceptors in Cardiac Myocytes Attenuates Neurohormone-Induced Hypertrophic Remodeling Through Nitric Oxide Synthase
- (2013) Catharina Belge et al. CIRCULATION
- Modulation of non-voiding activity by the muscarinergic antagonist tolterodine and the β3-adrenoceptor agonist mirabegron in conscious rats with partial outflow obstruction
- (2012) James I. Gillespie et al. BJU INTERNATIONAL
- Effects of Mirabegron, a Novel β3-Adrenoceptor Agonist, on Primary Bladder Afferent Activity and Bladder Microcontractions in Rats Compared With the Effects of Oxybutynin
- (2012) Naoki Aizawa et al. EUROPEAN UROLOGY
- Single dose pharmacokinetics and absolute bioavailability of mirabegron, a ?3-adrenoceptor agonist for treatment of overactive bladder
- (2012) Charlotte Eltink et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Cardioprotective Effect of Beta-3 Adrenergic Receptor Agonism
- (2012) Xiaolin Niu et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dynamic Changes of Edema and Late Gadolinium Enhancement After Acute Myocardial Infarction and Their Relationship to Functional Recovery and Salvage Index
- (2011) Erica Dall'Armellina et al. Circulation-Cardiovascular Imaging
- Beta3-Adrenoreceptor Stimulation Ameliorates Myocardial Ischemia-Reperfusion Injury Via Endothelial Nitric Oxide Synthase and Neuronal Nitric Oxide Synthase Activation
- (2011) Juan P. Aragón et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started